Epistaxis is a common problem among people of all ages and backgrounds. However, occasionally epistaxis can be severe enough to require emergency room admission. Among the treatment options for epistaxis, nasal packing is the most common approach. This approach requires a return visit to the clinic for removal of the packing. Additionally, there is a great deal of pain during the insertion and removal of this packing. This study aims to justify the further investigation of thrombin as a potential treatment approach for these patients. Thrombin could provide a treatment approach that reduces pain and eliminates the need for a return visit to the clinic.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1
5,000 IU, to nasal mucosa via syringe spray applicator
8 cm pack, inserted within the affected side between the septum and inferior turbinate via bayonet forceps
University of Kansas Medical Center
Kansas City, Kansas, United States
Cessation of Epistaxis
Time frame: baseline, day 4-6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.